Home

Venmax Drugs & Pharmaceuticals PE Ratio

Image

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAXDRUGS

PE

-

Last updated on: May 08, 2025

Key Highlights

  • The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd is 0 as of 08 May 10:13 AM .
  • The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Venmax Drugs & Pharmaceuticals Ltd is ₹ 28.55 as of 08 May 10:00 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd

No data available

Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd

Image

Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAXDRUGS

Share Price

₹ 28.55

1.33 (4.89%)

stock direction

Last updated on: May 08, 2025

Market Price of Venmax Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Venmax Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 May 202527.22
06 May 202527.81
05 May 202527.26
02 May 202526.52
30 Apr 202527.9
29 Apr 202529.21
28 Apr 202527.82
25 Apr 202526.5
24 Apr 202525.99
23 Apr 202525.49

SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd

Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Venmax Drugs & Pharmaceuticals Ltd14.26
Sun Pharmaceutical Industries Ltd427406
Divis Laboratories Ltd163113
Cipla Ltd121869
Torrent Pharmaceuticals Ltd111340
Mankind Pharma Ltd100259

PE Ratio of Venmax Drugs & Pharmaceuticals Ltd Explained

14.26

Market cap

0

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Venmax Drugs & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd

No data available

* All values are in %

About Venmax Drugs & Pharmaceuticals Ltd

  • Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998.
  • The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
  • It became a Public Limited Company on February 3, 1995 with 'Yenkey Drugs & Pharmaceuticals Limited'.
  • Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
  • Initially, the Company engaged in the business of pharmaceutical products, drug intermediaries & API's etc.

Venmax Drugs & Pharmaceuticals Ltd News Hub

Venmax Drugs & Pharmaceuticals to conduct board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au

Read more

16 Aug 24

Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter

Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J

Read more

13 Aug 24

Venmax Drugs & Pharmaceuticals to hold board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au

Read more

03 Aug 24

Venmax Drugs & Pharmaceuticals to hold AGM

Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w

Read more

27 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Venmax Drugs & Pharmaceuticals Ltd

What is the current PE Ratio of Venmax Drugs & Pharmaceuticals Ltd?

The Current PE Ratio of Venmax Drugs & Pharmaceuticals Ltd is 0.0 as on 8 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 8 May 2025.

What was the PE Ratio of Venmax Drugs & Pharmaceuticals Ltd last year?

The PE Ratio of Venmax Drugs & Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Venmax Drugs & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Venmax Drugs & Pharmaceuticals Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Venmax Drugs & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Venmax Drugs & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Venmax Drugs & Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by 63.8.

How does the PE ratio of Venmax Drugs & Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Venmax Drugs & Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Venmax Drugs & Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio?

The PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Venmax Drugs & Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Venmax Drugs & Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Venmax Drugs & Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Venmax Drugs & Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Venmax Drugs & Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions